Gilead Sciences | GILD - EPS Earnings Per Share

Stock Price
127.73
Daily Change
-2.67 -2.05%
Monthly
-6.32%
Yearly
20.11%
Q2 Forecast
127.61

Gilead Sciences reported $1.86 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.9 1.81 May/07
FY2025Q4 Dec/2025 1.86 1.89 1.90 Feb/10
FY2025Q3 Sep/2025 2.47 2.16 2.02 Oct/30
FY2025Q2 Jun/2025 2.01 1.94 2.01 Aug/07
FY2025Q1 Mar/2025 1.81 1.76 3.34 Apr/24




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.21 0.51 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.88 0.35 Mar/2026
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025